DIRECTA PLUS PLC

Board/Management Information • Oct 11, 2021

National Storage Mechanism | Additional information

RNS Number : 5768O

Directa Plus PLC

11 October 2021

11 October 2021

Directa Plus plc

("Directa Plus" or the "Company")

Investor Presentation

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that the Company will be hosting a presentation for investors and potential investors at 0930h BST on Friday 15 October 2021 on the Investor Meet Company platform.

Giulio Cesareo, Founder & CEO, and Giorgio Bonfanti, CFO, will give a live presentation relating to the 1H 2021 Results (announced on 29 September 2021) and the outlook for Directa Plus.  Questions can be submitted pre-event via the Investor Meet Company dashboard up until 9:00am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Directa Plus via:

https://www.investormeetcompany.com/directa-plus-plc/register-investor

Investors who already follow Directa Plus on the Investor Meet Company platform will automatically be invited.

For further information please visit www.directa-plus.com or contact:

Directa Plus plc	+39 02 36714458
Giulio Cesareo, CEO Giorgio Bonfanti, CFO
Cenkos Securities plc (Nominated Adviser and Joint Broker)	+44 131 220 6939
Neil McDonald Adam Rae
Singer Capital Markets (Joint Broker)	+44 20 7496 3069
Rick Thompson Phil Davies
Tavistock (Financial PR and IR)	+44 20 7920 3150
Simon Hudson Heather Armstrong

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+® products).  In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+® products.  All our products are hypoallergenic, non-toxic and sustainably produced.

-ends-

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAFZMMGNGVGMZM